
Vissco Next is a franchise brand in the Healthcare Products sector in India, established in 1963 and franchising since 2021. A new unit needs an investment of ₹10L - 20L and 120 - 500 sq ft of space. It has 20-50 outlets and is headquartered in Mumbai, Maharashtra. The brand is expanding in Andaman and Nicobar Islands, Andhra Pradesh and Arunachal Pradesh and 32 more locations.
Vissco Next sells orthopaedic supports and mobility aids such as braces, wheelchairs, walkers and crutches. The Mumbai-based company dates to 1963 and began franchising in 2021. A franchise unit needs ₹10-20 lakh in total investment, including a ₹1 lakh franchise fee, in 120-500 sq ft of space, and the brand lists a 0% royalty.
Vissco Next is a manufacturer of orthopaedic and mobility aids, headquartered in Mumbai, Maharashtra. The company traces its beginnings to 1963, when founder Chinubhai Gandhi set out to make an affordable support product after his wife suffered from cervical pain. It started franchising in 2021.
The range covers braces and supports for joints, pain management products, rehabilitation devices and mobility aids such as wheelchairs, walkers and crutches. The brand says it has 20-50 outlets and a presence across 35 states and union territories.
The brand states a total investment of ₹10-20 lakh per unit, with a franchise fee of ₹1 lakh. It lists the royalty as 0%. The investment would normally go towards store fit-out, opening inventory and deposits; the brand has not published the exact split.
It estimates a payback of 1-2 years and an ROI of 183%. These are the brand's projections and depend heavily on footfall, rent and stock turnover.
The unit model needs a commercial space of 120-500 sq ft. The brand prefers upmarket residential areas, malls and high streets. A franchisee gets an exclusive territory. The agreement is for 5 years and renewable.
The brand lists opening support, field assistance and IT systems. Training takes place at its head office and covers product knowledge, sales and customer service. It also says it provides marketing and branding support.
This format suits entrepreneurs and healthcare-linked professionals, such as pharmacists or physiotherapy practitioners, who want a specialist retail store. Demand comes from older customers, people recovering from injury or surgery, and families buying mobility equipment.
| Total investment | ₹10L - 20L |
|---|---|
| Unit franchise investment | ₹10L - 20L |
| Franchise fee | ₹1L |
| Royalty fee | 0% |
| Payback period | 1–2 years |
| Expected ROI | 183% |
| Space required | 120 - 500 sq ft |
| Property types | Commercial |
| Preferred locations | Upmarket residential I Malls I High streets |
| Agreement term | 5 years (renewable) |
| Exclusive territory | Yes |
| Training provided | Yes |
|---|---|
| Training location | Headoffice |
| Field assistance | Yes |
| IT support | Yes |
| Opportunity type | Franchise |
|---|---|
| Franchise model | Unit |
| Headquarter | Mumbai, Maharashtra |
| Established | 1963 |
| Franchising since | 2021 |
| Franchise outlets | 20-50 |
A Vissco Next franchise needs a total investment of ₹10-20 lakh, according to the brand. This includes a franchise fee of ₹1 lakh.
Vissco Next lists its royalty as 0%. Confirm this in the agreement, along with any stock purchase requirements.
A Vissco Next store needs 120-500 sq ft of commercial space, preferably in an upmarket residential area, mall or high street.
The brand estimates a Vissco Next payback of 1-2 years and an ROI of 183%. These are the brand's own estimates.
Vissco Next sells orthopaedic supports, braces, pain relief products, rehabilitation devices and mobility aids such as wheelchairs, walkers and crutches.
Vissco Next is headquartered in Mumbai, Maharashtra, and traces its history to 1963.
Vissco Next states that it provides opening support, field assistance, IT systems and training at its head office.
The Vissco Next franchise agreement is for 5 years and can be renewed.
Last updated . Information is compiled from public sources and brand submissions and may change — verify the details with Vissco Next before investing.


